SCHEMBL1123650

SCHEMBL1123650

CCCCCCCCCCCCCCCC(=O)C(CCCCCCCCCCCCC)C(=O)OCC

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.48
FFAR4 Q5NUL3 1/20 0.44
FFAR1 O14842 1/20 0.44
DGKA P23743 1/20 0.44
ZDHHC7 Q9NXF8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2717743 1.00 CES2 (0.48) CES2FFAR4FFAR1DGKAZDHHC7
SCHEMBL29268682 0.94 DGKA (0.51) DGKA
SCHEMBL6311064 0.89 TDP1 (0.42) CES2
SCHEMBL29042643 0.88 NAAA (0.47) CES2DGKA
SCHEMBL29042642 0.88 NAAA (0.47) CES2DGKA
SCHEMBL28909193 0.88 NAAA (0.47) CES2DGKA
SCHEMBL1173131 0.88 NAAA (0.47) CES2DGKA
SCHEMBL29066706 0.88 NAAA (0.47) CES2DGKA
SCHEMBL4849686 0.88 NAAA (0.47) CES2DGKA
SCHEMBL28678070 0.88 DGKA (0.47) CES2FFAR4FFAR1DGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1985672-B1 Phase Change Ink Compositions XEROX CORP (US) 2011-02-09 EP disclosed
US-7811370-B2 Phase change ink compositions XEROX CORPORATION (US) 2010-10-12 US disclosed
US-20080264288-A1 Phase change ink compositions XEROX CORPORATION. 2008-10-30 US disclosed
EP-1985672-A1 Phase Change Ink Compositions Xerox Corporation (US) 2008-10-29 EP disclosed
US-7384463-B2 Phase change ink containing amphiphilic molecule XEROX CORPORATION (US) 2008-06-10 US disclosed
US-20080100684-A1 PHASE CHANGE INK CONTAINING AMPHIPHILIC MOLECULE XEROX CORPORATION (US) 2008-05-01 US disclosed